Description

Oxandrolone 10 mg by Swiss Healthcare is a pharmaceutical-grade oral anabolic-androgenic steroid (AAS), originally developed for clinical treatment of muscle wasting, severe weight loss, osteoporosis, and burn recovery. Known for its mild androgenic profile, low hepatotoxicity, and minimal estrogenic activity, Oxandrolone is highly regarded in research exploring lean tissue preservation, recovery enhancement, and muscle regeneration.

Its DHT-derived structure prevents aromatization to estrogen and reduces the risk of common side effects such as gynecomastia or water retention. It has been widely studied for its role in catabolic conditions and performance recovery, with strong anabolic impact and favorable safety markers in both short- and long-term lab research.

Each bottle contains 100 oral tablets, dosed precisely at 10 mg, and is manufactured under strict pharmaceutical-grade conditions for consistent results in controlled environments.

Product Details

• Active Ingredient: Oxandrolone

• Concentration per Tablet: 10 mg

• Form: Oral tablets

• Package Size: 100 tablets per bottle

Pharmacokinetics

Oxandrolone has a half-life of approximately 9–12 hours, allowing for effective twice-daily administration. It is not aromatized to estrogen and exhibits low liver toxicity, making it suitable for longer research durations when properly monitored.

Usage Recommendations

• Typical Research Dosage (historical reference): 10–40 mg per day, depending on study protocol

• Current Use: Intended solely for research and laboratory purposes

• Administration: Oral

Disclaimer

This product is intended strictly for research and laboratory use only. It is not approved for human consumption or therapeutic application. Not for use by individuals under 18, pregnant or breastfeeding women, or those with underlying medical conditions. Handle in accordance with applicable laws and research safety standards.